Aurora Acquires Safari Flower Co., Accelerating Global Medical Cannabis Leadership | Cannabis Law Report | Where to buy Skittles Moonrock online

Learn where to order marijuana online. TOP QUALITY GRADE A++

Cannabyss Inc. is the best place online to buy top quality weed, cannabis, vape, marijuana and CBD products. Get your borderless orders delivered at the pickup spot with ease. Top Grade products for client satisfaction.

👉 Click here to Visit our shop! 🛒

[PRESS RELEASE] – EDMONTON, Alberta, April 15, 2026 – Aurora Cannabis Inc., a Canadian-based leading global medical cannabis company, announced it has acquired Safari Flower Co., an established EU GMP-certified cannabis cultivator and manufacturer. Aggregate consideration is valued at $26.5 million, subject to customary adjustments, and inclusive of a cash payment of $2 million that is contingent on satisfaction of certain conditions (the “transaction”).

“The acquisition of Safari Flower Company marks an important milestone for Aurora as we continue to purposefully invest in expanding our EU GMP capacity to support the rapidly growing international medical cannabis market,” Aurora Executive Chairman and CEO Miguel Martin said. “We intend to leverage our extensive plant science and operational expertise to increase the supply of high-quality, EU GMP-manufactured flower that further enhances our leadership in these expanding, high-margin and highly regulated markets. An enhanced supply chain will enable us to capture greater international market share while delivering superior quality and value to our most respected patients worldwide.”

Strategic Rationale

• Safari Flower Co.’s 59,000-square-foot, purpose-built EU GMP-certified indoor cultivation and manufacturing facility in Ontario, Canada, will provide the company with incremental capacity that is closely aligned with its existing cultivation and manufacturing sites.
• The increased capacity will be used to supply EU GMP flower to Aurora’s key international markets, including Germany, Australia, Poland and the U.K., and support further market expansion.
• This transaction is expected to deliver positive adjusted EBITDA contributions in fiscal year 2027, with incremental benefits in fiscal year 2028 and beyond as these assets are optimized within the company’s supply network.
• Aurora intends to leverage its plant science and operational expertise to realize operational efficiencies, improve cultivation yields and support commercial execution in the high-margin international markets.

Transaction Details

Aurora, through a wholly-owned subsidiary, indirectly purchased 100% of the shares of 9869247 Canada Limited (“Safari Flower Company”) for aggregate consideration valued at $26.5 million, inclusive of a cash payment of $2 million that is contingent on satisfaction of certain conditions. As consideration on closing, Aurora (i) issued the selling shareholder 2,417,180 common shares; and (ii) paid the selling shareholder $15 million in cash, subject to customary adjustments post-closing.